ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 0603

Survivin-dependent Regulation of Bivalent Chromatin and Its Relevance for Adaptive Immunity

Venkataragavan Chandrasekaran1, Nina Oparina2, Karin Andersson2, Malin Erlandsson2, Maria-Jose Garcia-Bonete3, Maja Jensen4, Gergely Katona5 and Maria Bokarewa6, 1Department of Rheumatology and Inflammation Research, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden, 2Department of Rheumatology and Inflammation Research, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Goteborg, Sweden, 3Department of Medical Biochemistry and Cell Biology, Institute of Biomedicine, University of Gothenburg, Gothenburg, Sweden, 4Department of Chemistry and Molecular Biology, Gothenburg, Sweden, 5Department of Chemistry and Molecular Biology, University of Gothenburg, Gothenburg, Sweden, 6Department of Rheumatology and Inflammation Research, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Göteborg, Sweden

Meeting: ACR Convergence 2022

Keywords: Epigenetics, Gene Expression, genomics, rheumatoid arthritis, T Cell

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, November 13, 2022

Title: RA – Etiology and Pathogenesis Poster

Session Type: Poster Session B

Session Time: 9:00AM-10:30AM

Background/Purpose: Bivalent chromatin (BvCR) is characterized by simultaneous binding of active and repressive modifications to the histone H3 proteins. Influencing expression of the genes, BvCR determine cell fate and lineage commitment of primary T cells. Survivin is important for T cell development in the thymus and in effector Th1 cell function, contributing to aggravation of autoimmune inflammation. Survivin physically binds to DNA, and mechanistic data point to its potential chromatin regulatory role. This study establishes the colocalization of survivin with BvCRs and deduces functional effect of their collaboration on adaptive immunity.

Methods: Chromatin from 14 primary CD4+ T cell cultures was immunoprecipitated with a survivin antibody, with H3K27ac, H3K27me3, H3K4me3 antibodies, and coupled with DNA sequencing (ChIPseq, Hiseq2000, Illumina). BvCR were identified as exact overlaps of the three histone H3 peaks. BvCR co-localized with survivin were found using the ‘ChIPPeakAnno’ Bioconductor package. BvCR within the gene regulatory elements (RE) were identified through the GeneHancer database. K27me3 and K27ac tag count differences indicated inactive and active BvCR. Survivin-dependent changeability of the H3 modifications in BvCR and differentially expressed genes (DEG) were identified by treatment of CD4+ cells with a survivin inhibitor YM155.

Results: Co-localization of survivin with individual H3 modifications was significantly less frequent compared to its overlap with BvCR (7.1% vs 29.8%, p=8.9e-13). Survivin containing (Surv-) BvCR were more prevalent (66%) compared to survivin-free BvCR (66% vs 34%, respectively). Notably, survivin peaks were 5.5-fold higher in BvCR compared to those co-localized with no, or any single H3 (p< 2.2e-16). Further comparison of Surv-BvCR (n=4085), and survivin-free BvCR (n=2131) demonstrated that survivin was mostly associated with inactive BvCR (OR1.29, p=6.6e-6), while no such specificity was found for the survivin-free BvCR.

Inhibition of survivin significantly affected all histone H3 modifications, where K27me3 tags were affected the most. Surv-BvCR in the inactive state were less frequently located in RE compared to those in active Surv-BvCR (p=7.2e-8) and in inactive survivin-free BvCR (p=1.9e-13). Survivin inhibition revealed that 25% of DEG were connected to the RE containing Surv-BvCR, which also were more frequently changeable. Pathway enrichment analysis of DEG showed enrichment of adaptive immune processes, DNA metabolism and nitrogen catabolism.

Conclusion: This study provides experimental evidence for binding specificity of survivin in BvCR of CD4+ T cells, which regulates CD4+ T cell renewal and has functional importance in resistance to autoimmunity.


Disclosures: V. Chandrasekaran, None; N. Oparina, None; K. Andersson, None; M. Erlandsson, None; M. Garcia-Bonete, None; M. Jensen, None; G. Katona, None; M. Bokarewa, None.

To cite this abstract in AMA style:

Chandrasekaran V, Oparina N, Andersson K, Erlandsson M, Garcia-Bonete M, Jensen M, Katona G, Bokarewa M. Survivin-dependent Regulation of Bivalent Chromatin and Its Relevance for Adaptive Immunity [abstract]. Arthritis Rheumatol. 2022; 74 (suppl 9). https://acrabstracts.org/abstract/survivin-dependent-regulation-of-bivalent-chromatin-and-its-relevance-for-adaptive-immunity/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2022

ACR Meeting Abstracts - https://acrabstracts.org/abstract/survivin-dependent-regulation-of-bivalent-chromatin-and-its-relevance-for-adaptive-immunity/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology